Hip Denervation and Intra-articular Hydration in Damaged Hip in Axial Spondyloarthritis Patients
NCT ID: NCT05219084
Last Updated: 2022-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
60 participants
INTERVENTIONAL
2021-12-01
2022-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: The aim of this study is to evaluate the effect of hip denervation (HD) and intra-articular hydration (IAH) on pain, function score, hip mobility scores in a cohort of axial SpA patients with grade 3 and 4 hip BASRI scores.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Fluoroscopic Guided Atlantoaxial Joint Injection on Head and Neck Pain and Sleep Quality in RA Patients
NCT03606707
Reliability of IBP Criteria & Activity Scores in Patients With AxSpA
NCT05327140
Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement
NCT01292616
A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)
NCT03258814
The Relationship Between Magnetic Resonance Imaging (MRI) Scores and Sensory Testing in Axial Spondyloarthritis
NCT05021783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo group
5ml of normal; saline-injected subcutaneously
Control group
Normal; saline was injected subcutaneously
Hip denervatiopn
Hip denervation with lidocaine 2% to each genicular branch, 2ml at each point
hip denervation
Lidocaine 2% 2ml was injected into each genicular nerve
Inra-articular hydration
10 ml of normal saline injected inside the hip under ultrasound guidance
intra-articular hydration
10 ml; of normal; saline were injected inside the hip joint
compined group
hip denervation and intra-articular hydration were conducted together in this group
Combined group
hip denervation and intra-articular hydration were conducted together
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combined group
hip denervation and intra-articular hydration were conducted together
Control group
Normal; saline was injected subcutaneously
hip denervation
Lidocaine 2% 2ml was injected into each genicular nerve
intra-articular hydration
10 ml; of normal; saline were injected inside the hip joint
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Axial; SpA fulfilled ASA criteria
* BASRI score grade 3 or 4 for one hip at least
Exclusion Criteria
* Axial; SpA with normal hip or hip involvement less than 3 on BASRI score
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Suez Canal University
OTHER
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mahrous
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Elsaman
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SC 250
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.